Continuing Medical Education (CME)
Over the past 20+ years, faculty from Michigan Medicine's Gastroenterology & Hepatology and Transplant Surgery sections have hosted a number of well-received CME courses for practicing physicians wanting to keep up with the latest developments in clinical gastroenterology and hepatology. Experienced faculty from the University of Michigan provide a mix of clinical research findings along with case-based learning in their programs.
Liver Disease Wrap-Up
This seminar summarizes presentations made at the yearly American Association for the Study of Liver Diseases (AASLD) meeting. New information regarding the management of hepatitis B, fatty liver disease, liver cancer, and complications of portal hypertension and cirrhosis have all been presented.
Michigan Medicine Liver Round-Up
New information and case based discussions regarding the management of hepatitis C, patients with hepatic steatsosis, and alcoholic liver disease have been presented.
Advances in Gastroenterology and Hepatology
This conference sheds new light on developments within the gastroenterology and hepatology disciplines. Experts in their fields provide case-based lectures on specific diseases, disorders, and procedures.
View the Department of Internal Medicine CME Course Calendar.
June 2020 HCV Experience
HCV Outreach podcast
Liver Disease and At-Risk Communities: Hepatologist Ponni Perumalswami Works on Outreach
APASL-WGO Virtual Summit 2020: Dr. Anna Lok "Assessment for treatment candidacy of patients infected with chronic HBV in COVID-19 pandemic era (noninvasive only or liver biopsy)"
HBV ECHO 2019:
Highlights from ECHO HBV Bootcamp
Module One: Screening & Having the Conversation
ECHO HBV Bootcamp C - Module Two: Serology (Part One)
ECHO HBV Bootcamp C- Module Three: Serology (Part Two)
ECHO HBV Bootcamp C - Module Four: HBV Management/Treatment
Module Five: HBV Management in Special Populations
Hepatitis B Dispelling Myths and Misconceptions - Focus on Transmission & Prevention- HBV United
Dr. Anna Lok Novel Therapeutics for HBV in 2018
2016 HBV Program for National Association of Continuing Education
Keeping patients with cirrhosis out of the hospital
Grand Rounds - Dr Elliott Tapper 3/4/21
May 2020 Dr. Parikh on the Role of Radiation in HCC
February 2020 Michigan Minds: Organ Donation Policy
November 2020 Conversations with an Expert, Ep 2: Management of alcohol use disorder in transplant recipients
April 2020 Clinical Insights: COVID-19 and the Liver - Case Studies and Updates 04.07.20 >2700 views
Hepatic Encephalopathy 2019: Flipping the Script
Dec 2019 Michigan Genomics Initiative Workshop with MD, PhD, MPH
Alcohol Associated Liver Disease in the US: Another Disease of Despair?
Human Genetics Defines New Causes and Possible Treatments for Human Obesity and Nonalcoholic Fatty Liver Disease
April 2019 Emory University Medicine Grand Rounds: An update on drug-induced liver injury 4/2/19
An Overview of Hepatic Encephalopathy
Cirrhosis and Portal Hypertension >9000 views
July 2018 Advanced Liver Disease Case Discussions
July 2018 Non-alcoholic fatty liver disease and Alcoholic liver disease
July 2018 Hepatocellular Carcinoma and Hepatotoxicity
Nov 2015 Efficacy of Sorafenib in Advanced Hepatocellular Carcinoma - SEER Data Analysis
MCP 60 Seconds With Dr Elliott Tapper on the Ammonia Hypothesis
Dame Sheila Sherlock, MD, Visiting Lectureship in Hepatology
In 1959, Dr. Sheila Sherlock was appointed to the Chair of the Department of Medicine at the Royal Free Hospital School of Medicine. She was the first woman to be appointed to the Chair of Medicine in a British medical school. Dr. Sherlock’s unit at the Royal Free was the “Mecca of Hepatology” for referring physicians worldwide and THE Liver Center for trainees in Hepatology from the 1960s to the 1980s. Dr. Sherlock published more than 600 papers, and wrote or edited over 25 books. She trained more than 300 physicians and investigators, many of whom went on to be directors of liver units all over the world. She remained very close to all her trainees and considered every one as part of the “Sherlock Family”. In 1978, Dr. Sherlock was knighted by the Queen of England as “Dame Commander of the British Empire” for her contributions to medicine.
Education and training of other physicians in liver diseases has been a cornerstone of Dr. Sherlock’s work. Keith Henley, MD, the first hepatologist at the University of Michigan and Anna Lok, MD, who has been Director of Clinical Hepatology at the University of Michigan since 1995, both received their training in hepatology under the tutelage of Dame Sheila Sherlock.
To honor her mentor, Dr. Lok and the Division of Gastroenterology and Hepatology established this lectureship.
Each year, a world leader in hepatology will be invited to present the Dame Sheila Sherlock, MD Lecture on an important topic in liver disorders.